23/01/2026 14:50
UBS raised the target price for RemeGen (09995) to HKD120 from HKD63.8 and upgraded the rating to "buy" from "neutral".
The research house said it is positive on the recent partnership with AbbVie.
【你點睇？】巴士安全帶新例正式實施，乘客須配戴安全帶，違者可被檢控。你認為新例對提升乘車安全有多大幫助？你最擔心新例會帶來哪方面問題？► 立即投票
上一篇新聞︰23/01/2026 16:06 {I-bank focus}HSBC raises CTF Services (00659) to HKD10.1
下一篇新聞︰22/01/2026 16:03 {I-bank focus}Macquarie raises Chow Tai Fook to HKD19.8
26/01/2026 16:01 {I-bank focus}Macquarie raises ASMPT (00522) to HKD133
26/01/2026 14:40 {I-bank focus}Citi raises Weichai Power (02338) to HKD34
22/01/2026 14:45 {I-bank focus}UBS raises ASMPT (00522) to HKD135
21/01/2026 16:01 {I-bank focus}Daiwa lowers Tencent (00700) to HKD725
20/01/2026 16:02 {I-bank focus}Citi lowers Bud APAC (01876) to HKD11.4
